Subscribe to Newsletter
Business & Profession Business and Innovation, Health Economics and Policy

Business in Brief

Left: David Guyer, right: Ted Danse.

  • Visus Therapeutics has appointed David Guyer as the chairman of the Board, while Ted Danse has become head of business development (both pictured above). Guyer has over 30 years’ experience in ophthalmic drug development, including commercialization of the first anti-VEGF drug for AMD. Danse has held key executive roles in multiple life science companies, including Allergan and Neurotech. 
  • Erin Parsons has joined the Board of Directors at Alimera Sciences. Parsons brings with her more than 20 years of experience overseeing scientific strategy, communications, advocacy, and educational programs in the ophthalmic industry, including the retina space. 
  • Rayner Surgical Group has acquired Omeros Corporation’s ophthalmology assets, including Omidria, a product used widely for mydriasis maintenance during surgery, protecting the eye from cystoid macular edema, and reducing post-operative pain without the use of opioids. The transfer will be complete by the end of 2021. 
  • EyePoint Pharmaceuticals and ImprimisRx announced in a joint press release the expansion of a commercial alliance in which ImprimisRx will assume full responsibility for US sales and marketing for DEXYCU (dexamethasone intraocular suspension) 9%, for the treatment of post-operative inflammation following ocular surgery.
  • Ophthalmic Sciences has launched IOPerfect, a contactless device that measures IOP and monitors glaucoma using artificial intelligence as part of a VR-like headset. The device uses tele-diagnosis, and allows patients to monitor the IOP at home without the need of recalibration or the use of additional therapeutics. 
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Aleksandra Jones

Editor of The Ophthalmologist

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: